Preparing Winning Proposals

Preparing Winning Proposals

#BMCRoadshow Wifi: LOTTEHOTEL No password required Making open access work for you BioMed Central Global Roadshow Seoul December 4, 2015 Karen Cheng Journal Development Editor Eunice Choi Open Access Publishing Executive Alex Christoforou Head of Customer Services, Memberships Stephanie Diment Editorial Director Louisa Flintoft Editor, Genome Biology Sara Ho Assistant Acquisitions and Development Editor Ben Johnson Associate Publisher Ella Kim Editor Lauren Kim Editor Fiona Pring Senior Acquisitions and Development Editor Tom Aldridge Events Manager Penny Webb Senior Editor, Editor Communications 2 Making open access work for you Program this morning Welcome and Introduction 9:25 Genome Biology- Making an Impact 9:40 How to write a paper and get published, part 1 a. Choosing a journal b. Preparing the article c. Publication Ethics 10:20 Coffee Break (30mins) 10:50 How to write a paper and get published, part 2 d. Responding to editors and peer-reviewers e. Dealing with rejection f. Tips to summarize 11:20 Open access in Korea- has it made a difference? 11:50 Biomaterials Research- from subscription to open access 12:00 Lunch (60mins) 3 A history of Open Access BioMed Central founded University of Hong Kong’s 3rd August 1998 Open Access mandate BioMed Central October 2008 Open Access Korea publishes first article founded th 19 July 2000 Bethesda Statement on 2010 Open Access Publishing 20th June 2003 Budapest Open SpringerOpen Access Initiative launches th 14 January 2002 1st June 2010 Launch of Berlin Declaration on PubMed Central Open Access to 1st February 2000 Knowledge in the Sciences and Humanities 22nd October 2003 Types of Open Access Publishing Open Access market growth Number of Articles in Web of Science 2004-2014 Publishing Ethics BioMed Central is committed to maintaining high standards through full and stringent peer review. • Peer review is the responsibility of our trusted Editors, in some cases review is open e.g. Biology Direct, GigaScience • BioMed Central is a member of Committee on Publication Ethics (COPE) http://publicationethics.org/ • BioMed Central Publishes under Creative Commons license, CC-BY http://creativecommons.org/licenses/by/2.0/ • BioMed Central is a founder member of Open Access Scholarly Publishers Association (OASPA) http://oaspa.org/ BioMed central today IMPACT IMPACT FACTOR FACTOR 10.81 7.98 IMPACT FACTOR IMPACT 7.36 FACTOR 5.33 IMPACT IMPACT FACTOR FACTOR 6.56 7.11 IMPACT FACTOR IMPACT 6.56 FACTOR 5.49 IMPACT FACTOR IMPACT 6.04 FACTOR 4.84 8 BioMed central today 45.5 million monthly page views More than 2 million 10.8 million unique monthly visitors More than 290 registrants journals BioMed Central locations Over 600 institutional members Shanghai 80% of BioMed Central journals which are four years old or more, either have an impact factor or will receive one soon BioMed Central today (2) 2000 BioMed Central is founded 2008 BioMed Central becomes a division of Springer May 2015 Springer merges with Nature to become… SPRINGER NATURE Our goals: • Outstanding service in OA to authors • Leadership in innovation, which is why Springer Nature is prioritizing “Open Research” including open data • Through OA approaches, to facilitating collaborative and interdisciplinary research to solve today’s global challenges BioMed Central, looking forward Open Research Group, SPRINGER NATURE We are: BioMed Central Springer Open, Springer Plus Nature Communications Scientific Reports Nature Partner Journals Scientific Data .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    11 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us